Journal of Clinical Endocrinology & Metabolism, Vol 66, 672-677, Copyright © 1988 by Endocrine Society

ARTICLES

Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin

M Dowsett, B Cantwell, A Lal, SL Jeffcoate and AL Harris
Department of Biochemical Endocrinology, Chelsea Hospital for Women, London, United Kingdom.

Twenty-one postmenopausal women with advanced breast cancer were treated with monthly 3.6-mg sc injections of the LHRH agonist goserelin [D-Ser-(But)6, Azgly10-LHRH] to determine whether the resultant endocrine changes could provide an explanation for the clinical responses that occur during therapy with this agent. After 4 weeks, serum gonadotropin levels were less than 10% of pretreatment levels, whereas serum PRL levels did not change. A significant decrease in serum testosterone occurred in 19 of 20 patients; this fall was associated with a 22% fall in serum estradiol levels. Serum androstenedione levels also decreased, but serum estrone and dehydroepiandrosterone sulfate (DHAS) levels did not. The lack of fall in serum DHAS levels indicates that the changes in androgen levels were a result of reduced ovarian secretion, and the reduced estradiol levels were a consequence of reduced precursor (i.e. testosterone) availability. The continued dependence of ovarian androgen secretion on gonadotropin stimulation after the menopause may explain the responses of some patients to LHRH agonists and some other therapeutic agents of unknown or uncertain modes of action.

This article has been cited by other articles:

				S. Basaria and A. S. Dobs Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4743 - 4752. [Abstract] [Full Text] [PDF]

				J. C. Havelock, W. E. Rainey, K. D. Bradshaw, and B. R. Carr The post-menopausal ovary displays a unique pattern of steroidogenic enzyme expression Hum. Reprod., January 1, 2006; 21(1): 309 - 317. [Abstract] [Full Text] [PDF]

				W. de Ronde, A. Hofman, H. A P Pols, and F. H de Jong A direct approach to the estimation of the origin of oestrogens and androgens in elderly men by comparison with hormone levels in postmenopausal women Eur. J. Endocrinol., February 1, 2005; 152(2): 261 - 268. [Abstract] [Full Text] [PDF]

				F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF]

				S. Jabara, L. K. Christenson, C. Y. Wang, J. M. McAllister, N. B. Javitt, A. Dunaif, and J. F. Strauss III Stromal Cells of the Human Postmenopausal Ovary Display a Distinctive Biochemical and Molecular Phenotype J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 484 - 492. [Abstract] [Full Text] [PDF]

				M. Nagamani and R. J. Urban Expression of Messenger Ribonucleic Acid Encoding Steroidogenic Enzymes in Postmenopausal Ovaries Reproductive Sciences, January 1, 2003; 10(1): 37 - 40. [Abstract] [PDF]

				B. Couzinet, G. Meduri, M. G. Lecce, J. Young, S. Brailly, H. Loosfelt, E. Milgrom, and G. Schaison The Postmenopausal Ovary Is Not a Major Androgen-Producing Gland J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5060 - 5066. [Abstract] [Full Text] [PDF]

				G. Laughlin and E. Barrett-Connor Postmenopausal Testosterone J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1843 - 1844. [Full Text]

				C. Longcope Endocrine Function of the Postmenopausal Ovary Reproductive Sciences, January 1, 2001; 8(1_suppl): S67 - S68. [Abstract] [PDF]